Journey Medical (DERM) EBITDA (2020 - 2026)
Journey Medical (DERM) EBITDA from Sep 30, 2020 to Mar 31, 2026. The TTM Journey Medical (DERM) EBITDA is -$5.83M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Journey Medical (DERM) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +12.12% |
| 3 Years TTM | -45.57% |
| All Time TTM | -28.28% |
Annual EBITDA change of Journey Medical (DERM)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$1.34M | -82.53% |
| 2025 | -$7.67M | -35.60% |
| 2024 | -$12M | +517.10% |
| 2023 | -$1.93M | -92.99% |
| 2022 | -$28M | -21.01% |
| 2021 | -$35M | -543.77% |
| 2020 | $7.86M | N/A |